Skip to main content
. 2023 Jan 13;20(2):1479. doi: 10.3390/ijerph20021479
CTCAE common terminology criteria for adverse events
CIPN chemotherapy-induced peripheral neuropathy
EQ VAS self-evaluation of the health status measured by the visual analog scale
HRQOL health-related quality of life
O3T ozone treatment
Q1–Q3 quartiles 1 and 3
QOL quality of life
RCT randomized controlled trials
VAS visual analog scale